OR WAIT null SECS
February 20, 2024
As part of the agreement, Novo will be paid both development and commercial milestone payments for NN-8828, is currently in Phase II of non-dermatological indications.
February 16, 2024
The financial commitment features construction of new warehouses in Pennsylvania and North Carolina.
February 13, 2024
The analysis notes that 60% of respondents were setting targets based on AI’s ability to either cut costs or boost productivity.
Roche and Repare came to terms on a deal in June 2022 to develop and commercialize camonsertib, which included a $125 million upfront payment and could have reached up to $1.2 billion based on clinical, regulatory, commercial, and sales milestones.
February 12, 2024
According to AbbVie, ImmunoGen's entire oncology portfolio could drive long-term revenue growth, giving the company a potential multi-billion dollar drug that is already on the market.
February 09, 2024
Technavio analysis notes that an increase drug patent expirations could be a contributing factor.
February 05, 2024
The acquisition expands Merck’s portfolio in the veterinary pharma space.
The deal is expected to help boost supply of Wegovy.
Pharma Commerce travels to Orlando for a pulse-check on this fast-evolving landscape in patient care.
An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them.